Open AccessOsimertinib and dihydroartemisinin: a novel drug combination targeting head and neck squamous cell carcinoma
Author(s) -
Imane Chaib,
Xueting Cai,
David Lligé,
Mariacarmela Santarpía,
Eloísa JantusLewintre,
Martyna Filipska,
Carlos Pedraz,
Jean Cui,
Jie Yang,
Miao Jing,
Rongwei Sun,
Jillian Wilhelmina Paulina Bracht,
Masaoki Ito,
Jordi CodonyServat,
Niki Karachaliou,
Andrés Aguilar,
Rafael Rosell,
Peng Cao
Publication year - 2019
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2019.10.80
Subject(s) - osimertinib , head and neck squamous cell carcinoma , cancer research , medicine , in vivo , gefitinib , epidermal growth factor receptor , pharmacology , erlotinib , head and neck cancer , cancer , biology , microbiology and biotechnology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom